ATE364630T1 - Neuer leptin-antagonist - Google Patents

Neuer leptin-antagonist

Info

Publication number
ATE364630T1
ATE364630T1 AT03102619T AT03102619T ATE364630T1 AT E364630 T1 ATE364630 T1 AT E364630T1 AT 03102619 T AT03102619 T AT 03102619T AT 03102619 T AT03102619 T AT 03102619T AT E364630 T1 ATE364630 T1 AT E364630T1
Authority
AT
Austria
Prior art keywords
leptin
antagonist
receptor
leptin antagonist
leptin receptor
Prior art date
Application number
AT03102619T
Other languages
English (en)
Inventor
Jan Tavernier
Frank Peelman
Original Assignee
Vlaams Interuniv Inst Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech filed Critical Vlaams Interuniv Inst Biotech
Application granted granted Critical
Publication of ATE364630T1 publication Critical patent/ATE364630T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT03102619T 2003-08-21 2003-08-21 Neuer leptin-antagonist ATE364630T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03102619A EP1508575B1 (de) 2003-08-21 2003-08-21 Neuer Leptin-Antagonist

Publications (1)

Publication Number Publication Date
ATE364630T1 true ATE364630T1 (de) 2007-07-15

Family

ID=34042976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03102619T ATE364630T1 (de) 2003-08-21 2003-08-21 Neuer leptin-antagonist

Country Status (4)

Country Link
EP (1) EP1508575B1 (de)
AT (1) ATE364630T1 (de)
DE (1) DE60314412T2 (de)
ES (1) ES2289235T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110167965A (zh) * 2016-11-08 2019-08-23 瑞泽恩制药公司 拮抗瘦素受体的抗原结合蛋白

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6471956B1 (en) * 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
WO1997020933A2 (en) * 1995-12-06 1997-06-12 Schering Corporation MUTATIONAL VARIANTS OF MAMMALIAN Ob GENE PROTEINS

Also Published As

Publication number Publication date
DE60314412T2 (de) 2008-02-14
DE60314412D1 (de) 2007-07-26
ES2289235T3 (es) 2008-02-01
EP1508575B1 (de) 2007-06-13
EP1508575A1 (de) 2005-02-23

Similar Documents

Publication Publication Date Title
ATE420863T1 (de) Substituierte piperidinverbindungen zur verwendung als h3 histaminerezeptorantagonisten
BRPI0414592A (pt) antagonistas de receptores de trombina
ATE494285T1 (de) Muscarinische acetylcholin-rezeptor-antagonisten
DE60217147D1 (de) Lactamderivaten zur verwendung als humane 11cby rezeptorantagonisten
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
DE602004017608D1 (de) Cgrp-rezeptorantagonisten
ATE494284T1 (de) Tricyclischer thrombinrezeptorantagonist
ATE557036T1 (de) Ox40 rezeptor bindende agenzien
IS8307A (is) Fenýl eða pýridýl amíð efnasambönd sem prostaglandín E2 mótlyf
ATE461191T1 (de) N-substituierte 2-oxodihydropyridinderivate als npy antagonisten
MA29135B1 (fr) Potentialisateurs de recepteurs du glutamate
ATE440840T1 (de) Quinuclidin-derivate bindend an muscarin-m3- rezeptoren
DE60304889D1 (de) Heterosubstituierte arylessigsäure-co-initiatoren für ir-empfindliche zusammensetzungen
ATE479655T1 (de) Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
EE200300092A (et) EDb-fibronektiinidomeeni retseptor
DE60314412D1 (de) Neuer Leptin-Antagonist
FR2890671B3 (fr) Plaque d'egout universelle pour route de type reglable
DK1696907T3 (da) PDK-1/AKT Signalinhibitorer
FR2836940B3 (fr) Pave de beton
DE50206910D1 (de) Substituierte y-lactonverbindungen als nmda-antagonisten
IS8388A (is) Blandan af serótónín endurupptökuhindra og histamín 3 viðtaka mótlyfi, öflugum verka eða hlutaverka
ATE299138T1 (de) Mandelatsalze von substituierten tetrazyklischen tetrahydrofuranderivaten
DE60319989D1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
ATE497947T1 (de) Neue 1,3-disubstituierte azetidinderivate zur verwendung als liganden des 5ht2a-rezeptors
DE60211763D1 (de) Tocotrienole als Inhibitoren der Neovaskularization.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1508575

Country of ref document: EP

REN Ceased due to non-payment of the annual fee